Abstract
MOST patients with non-insulin-dependent diabetes mellitus are resistant to both endogenous and exogenous insulin1. Insulin resistance precedes the onset of this disease2 –4, suggesting that it may be an initial abnormality. Insulin-receptor kinase activity is impaired in muscle, fibroblasts and other tissues of many patients with non-insulin-dependent diabetes mellitus5, but abnormalities in the insulin-receptor gene do not appear to be the cause of this decreased kinase activity6, 7. Skin fibroblasts from certain insulin-resistant patients contain an inhibitor of insulin-receptor tyrosine kinase8, 9. Here we show that this inhibitor is a membrane glycoprotein, termed PC-1 (refs 10,11). We find that PC-1 activity is increased in fibroblasts from seven of nine patients with typical non-insulin-dependent diabetes mellitus. In addition, overexpression of PC-1 in transfected cultured cells reduces insulin-stimulated tyrosine kinase activity. These studies raise the possibility that PC-1 has a role in the insulin resistance of non-insulin-dependent diabetes mellitus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Reaven, G. M. Diabetes 35, 1595–1607 (1988).
Bogardus, C. et al. Diabetes 38, 1423–1432 (1989).
Warram, J. H. et al. A. Intern. Med. 113, 909–915 (1990).
Martin, B. C. et al. Lancet 340, 925–929 (1992).
Haring, H. & Obermaier-Kusser, B. Diabetes Metab. Rev. 5, 431–441 (1989).
Taylor, S. I. Diabetes 41, 1473–1490 (1992).
Moller, D. E. & Flier, J. S. New Engl. J. Med. 325, 938–948 (1991).
Sbraccia, P. et al. Diabetes 40, 295–299 (1991).
Maddux, B. A., Sbraccia, P., Reaven, G. M., Moller, D. E. & Goldfine, I. D. J. Clin. Endocr. Metab. 77, 73–79 (1993).
Buckley, M. F., Loveland, K. A., McKinstry, W. J., Garson, O. M. & Goding, J. W. J. biol, Chem. 265, 29, 17506–17511 (1990).
Funakoshi, I. et al. Archs Biochem. Biophys. 295, 180–187 (1992).
Yoshida, H., Fukui, S., Funakoshi, I. & Yamashina, I. J. Biochem. 93, 1641–1648 (1983).
Greene, S. F., Johnson, P. R., Eiffert, K. C., Greenwood, M. R. C. & Stern, J. S. Obesity Res. 2, 432–443 (1994).
Milazzo, G. et al. Cancer Res. 52, 3924–3930 (1992).
Myers, M. G. & White, M. F. Diabetes 42, 643–650 (1993).
Rebbe, N. F., Tong, B. D. & Hickman, S. Molec. Immun. 30, 87–93 (1993).
Oda, Y., Kuo, M-D., Huang, S. S. & Huang, J. S. J. biol. Chem. 266, 16791–16795 (1991).
Huang, R. et al. J. clin. Invest. 94, 560–567 (1994).
Forsayeth, J., Maddux, B. & Goldfine, I. D. Diabetes 35, 837–846 (1986).
Hartmann, K. K. P. et al. Endocrinology 127, 2038–2040 (1990).
Suva, L. J. et al. Gene 77, 95–105 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maddux, B., Sbraccia, P., Kumakura, S. et al. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 373, 448–451 (1995). https://doi.org/10.1038/373448a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/373448a0
This article is cited by
-
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes
Acta Diabetologica (2024)
-
Is type 2 diabetes an adiposity-based metabolic disease? From the origin of insulin resistance to the concept of dysfunctional adipose tissue
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2021)
-
GALNT2 as a novel modulator of adipogenesis and adipocyte insulin signaling
International Journal of Obesity (2019)
-
Liver ENPP1 protein increases with remission of type 2 diabetes after gastric bypass surgery
BMC Gastroenterology (2014)
-
Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs
Nature Chemical Biology (2014)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.